Arkolith/Insider Trading/XENE/Form 4

Mortimer Ian

PRESIDENT & CEO, DirectorXenon Pharmaceuticals Inc. (XENE) · full profile →Form 4 · filed Dec 9, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 8, 2025Sell(S)2K$46.32$93K6K
Dec 8, 2025Sell(S)9K$45.59$402K8K
Dec 5, 2025Sell(S)14K$45.03$647K17K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-313147) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML